CVS - Angiotensin Antagonists, CCBs, Vasodilators - Drugs affecting vascular tone Flashcards
Classes of angiotensin antagonists & examples
- ACE Inhibitors - Captopril, Enalipril
- AT1 Receptor Antagonists - Losartan, Valsartan
- Renin Inhibitors - Aliskiren
Actions of angiotensin II (5)
- Arteriolar vasoconstriction - increases bp
- NaCl reabsorption, K+ excretion, H2O retention
- Increased sympathetic activity
- Post pit - ADH secretion - CD H2O absorption
- Aldosterone secretion
Mechanism of action of ACEI
- Inhibits converting enzyme peptidyl dipeptidase (ATI to ATII) - inhibits RAAS - hypotension
- Inhibits bradykinin (potent vasodilator) degradation - stimulation of kallikrein-kinin system - hypotension
Uses of ACEI (3)
- Hypertension - by decreasing PVR, CO & HR unchanged
- Chronic Renal Failure - diminish proteinuria, stabilize fn
- Heart Failure, after MI
Toxicity of ACEI (4) + Contraindications (1)
- Severe Hypotension
- Acute Renal Failure - esp in bilat renal stenosis
- Hyperkalemia - esp in renal insufficiency/diabetes
- Dry Cough +/- wheezing & angioedema - due to bradykinin & substance P
- Pregnancy - 1st trimester - increased teratogenicity, 2nd/3rd trimester - fetal hypotension, anuria, renal failure
Mechanism of action of AT1R antagonist
- Antagonizes angiotensin II type 1 receptors - no effect on bradykinin, more selective, more complete effects
- Prolonged inhibition of AT1 - disinhibits renin secretion + increases circulating AII - increases ATIIR activation (vasodilation)
Mechanism of action of renin inhibitors
- Inhibits renin - involved in the rate limiting step for AII production
- Produces dose dependent reduction in plasma renin activity, AI, AII and aldosterone concentrations
Uses of renin inhibitors (2)
- Reduces BP - similar to ACEI/diuretics in safety, tolerability
- Prevents rise in renin activity - produced by ACEI/ARBs/diuretics
Compare Verapamil, Diltiazem, Nifedipine
(A) Lowering BP
(B) Vasodilator
(C) Cardiac Depressant
(A) V = D = N
(B) N > D > V
(C) V > D > N
Mechanism of action of CCBs
- L-type channel blockers, predominant type in cardiac/smooth muscle
- Blocks Ca channels on the inner side of membrane (binds more effectively to open and inactivated channels) - decreases frequency of opening in response to depolarization - reduced transmembrane calcium current
Uses of CCBs (4)
- Anti-HTN - sustained relaxation in smooth muscle - decreasd muscle tone - reduced bp
- Anti-angina - reduced cardiac contractility - decreases O2 requirements in patients with angina
- Anti-arrhythmia - slowed/blocked SAN & AVN conduction (Verapamil, Diltiazem)
- Cerebral Vasospasm following subarachnoid hemorrhage (Nimodipine)
Toxicity of CCBs (2) + Contraindications (1)
- Cardiac Depression (cardiac arrest, bradycardia, AV block, heart failure) - due to excessive inhibition of Ca influx - but rare
- Minor effects - flushing, dizziness, nausea, constipation (esp verapamil), peripheral edema
- Congestive Heart Failure
Mechanism of α-1 blockers
Prazosin, terazosin, doxazosin
Selectively blocks α-1 receptors in arterioles & venules - dilates both resistance & capacitance vessels - anti-HTN
Uses of α-1 blockers (3)
- Hypertension
- Prostate Hyperplasia
- Bladder Obstruction (urinary hesitancy)
Considerations when using α-1 blockers (3)
- Has 1st dose effect - marked postural hypotension - Give small first dose at bedtime
- Increased salt/water retention - Use with diuretics/β-blockers
- Mild, infrequent toxicities - dizziness, palpitations, headache, lassitude